Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

This time really seems to be…

“The four most expensive words in investing are: ‘This time it’s different’,” according to legendary investor and mutual fund pioneer Sir John Templeton.


GCV Energy 2020
19th November 2020
GCV Symposium 2020
7th December 2020
GCVI Summit 2021
27th January 2021
Velodyne visualises reverse merger
A year after reportedly hiring banks for an IPO, multi-corporate-backed Velodyne has instead chosen a reverse merger to list on the New York Stock Exchange.
Nasdaq receives Accolade in $220m IPO
Comcast, McKesson, Humana and Independence Health all scored exits as the health benefits services provider floated in an upscaled offering.
Caffeine rushes to $113m series D
The livestreaming broadcaster was valued at more than $600m in a round co-led by investors including Cox Enterprises and Fox Corporation.
CF PharmTech sees its way to $50m
Drug developer CF PharmTech has raised $50m in an SAIC-backed series F round just six months after closing $90m in series E funding.
VMware devours Datrium in acquisition deal
Samsung Catalyst Fund is exiting data recovery technology provider Datrium, which was valued at about $280m in its last funding round.
Evidation Health generates $45m results
McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m.
test reg